These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 21700680)

  • 1. BRCA1 loss induces GADD153-mediated doxorubicin resistance in prostate cancer.
    De Luca P; Vazquez ES; Moiola CP; Zalazar F; Cotignola J; Gueron G; Gardner K; De Siervi A
    Mol Cancer Res; 2011 Aug; 9(8):1078-90. PubMed ID: 21700680
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BRCA1 and p53 regulate critical prostate cancer pathways.
    De Luca P; Moiola CP; Zalazar F; Gardner K; Vazquez ES; De Siervi A
    Prostate Cancer Prostatic Dis; 2013 Sep; 16(3):233-8. PubMed ID: 23670255
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of HO-1 and BRCA1 Is Critical for the Maintenance of Cellular Homeostasis in Prostate Cancer.
    Labanca E; De Luca P; Gueron G; Paez A; Moiola CP; Massillo C; Porretti J; Giudice J; Zalazar F; Navone N; Vazquez E; De Siervi A
    Mol Cancer Res; 2015 Nov; 13(11):1455-64. PubMed ID: 26227317
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Down-regulation of BRCA1 and BRCA2 in human ovarian cancer cells exposed to adriamycin and ultraviolet radiation.
    Fan S; Twu NF; Wang JA; Yuan RQ; Andres J; Goldberg ID; Rosen EM
    Int J Cancer; 1998 Aug; 77(4):600-9. PubMed ID: 9679765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BRCA1 directs a selective p53-dependent transcriptional response towards growth arrest and DNA repair targets.
    MacLachlan TK; Takimoto R; El-Deiry WS
    Mol Cell Biol; 2002 Jun; 22(12):4280-92. PubMed ID: 12024039
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BRCA1 as a potential human prostate tumor suppressor: modulation of proliferation, damage responses and expression of cell regulatory proteins.
    Fan S; Wang JA; Yuan RQ; Ma YX; Meng Q; Erdos MR; Brody LC; Goldberg ID; Rosen EM
    Oncogene; 1998 Jun; 16(23):3069-82. PubMed ID: 9662340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BRCA1, a 'complex' protein involved in the maintenance of genomic stability.
    Savage KI; Harkin DP
    FEBS J; 2015 Feb; 282(4):630-46. PubMed ID: 25400280
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [DNA damage induces BRCA1 distribution alteration in prostate cancer cell lines].
    Wang CY; Sun SK; Fu WJ; Song T; Cai W; Gao JP; Hong BF; Wang XX; Wang H
    Zhonghua Nan Ke Xue; 2008 Aug; 14(8):685-9. PubMed ID: 18817338
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coordinate alterations in the expression of BRCA1, BRCA2, p300, and Rad51 in response to genotoxic and other stresses in human prostate cancer cells.
    Yuan R; Fan S; Wang JA; Meng Q; Ma Y; Schreiber D; Goldberg ID; Rosen EM
    Prostate; 1999 Jun; 40(1):37-49. PubMed ID: 10344722
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Fanconi anemia/BRCA pathway is involved in DNA interstrand cross-link repair of adriamycin-resistant leukemia cells.
    Yao C; Du W; Chen H; Xiao S; Huang L; Chen F
    Leuk Lymphoma; 2015 Mar; 56(3):755-62. PubMed ID: 24996439
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased expression of bHLH transcription factor E2A (TCF3) in prostate cancer promotes proliferation and confers resistance to doxorubicin induced apoptosis.
    Patel D; Chaudhary J
    Biochem Biophys Res Commun; 2012 May; 422(1):146-51. PubMed ID: 22564737
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Doxorubicin-resistant variants of human prostate cancer cell lines DU 145, PC-3, PPC-1, and TSU-PR1: characterization of biochemical determinants of antineoplastic drug sensitivity.
    David-Beabes GL; Overman MJ; Petrofski JA; Campbell PA; de Marzo AM; Nelson WG
    Int J Oncol; 2000 Dec; 17(6):1077-86. PubMed ID: 11078791
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic exploitation of tumor cell defects in homologous recombination.
    Powell SN; Kachnic LA
    Anticancer Agents Med Chem; 2008 May; 8(4):448-60. PubMed ID: 18473729
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ING3 is required for ATM signaling and DNA repair in response to DNA double strand breaks.
    Mouche A; Archambeau J; Ricordel C; Chaillot L; Bigot N; Guillaudeux T; Grenon M; Pedeux R
    Cell Death Differ; 2019 Nov; 26(11):2344-2357. PubMed ID: 30804473
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [BRCA1 and genomic stability].
    Fan WH; Zhan QM
    Ai Zheng; 2003 Mar; 22(3):331-5. PubMed ID: 12654199
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BRCA1 alterations with additional defects in DNA damage response genes may confer chemoresistance to BRCA-like breast cancers treated with neoadjuvant chemotherapy.
    Takada M; Nagai S; Haruta M; Sugino RP; Tozuka K; Takei H; Ohkubo F; Inoue K; Kurosumi M; Miyazaki M; Sato-Otsubo A; Sato Y; Ogawa S; Kaneko Y
    Genes Chromosomes Cancer; 2017 May; 56(5):405-420. PubMed ID: 28124401
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of candidate biomarkers to predict cancer cell sensitivity or resistance to PARP-1 inhibitor treatment.
    Oplustilova L; Wolanin K; Mistrik M; Korinkova G; Simkova D; Bouchal J; Lenobel R; Bartkova J; Lau A; O'Connor MJ; Lukas J; Bartek J
    Cell Cycle; 2012 Oct; 11(20):3837-50. PubMed ID: 22983061
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cathepsin E enhances anticancer activity of doxorubicin on human prostate cancer cells showing resistance to TRAIL-mediated apoptosis.
    Yasukochi A; Kawakubo T; Nakamura S; Yamamoto K
    Biol Chem; 2010 Aug; 391(8):947-58. PubMed ID: 20482316
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BRCA1 is required for hMLH1 stabilization following doxorubicin-induced DNA damage.
    Romeo F; Falbo L; Di Sanzo M; Misaggi R; Faniello MC; Viglietto G; Cuda G; Costanzo F; Quaresima B
    Int J Biochem Cell Biol; 2011 Dec; 43(12):1754-63. PubMed ID: 21864706
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential targeting of androgen and glucocorticoid receptors induces ER stress and apoptosis in prostate cancer cells: a novel therapeutic modality.
    Yemelyanov A; Bhalla P; Yang X; Ugolkov A; Iwadate K; Karseladze A; Budunova I
    Cell Cycle; 2012 Jan; 11(2):395-406. PubMed ID: 22223138
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.